Evolution of the Average Target: IMPACT Therapeutics, Inc

Evolution of the Target Price: IMPACT Therapeutics, Inc

Changes in Analyst Recommendations: IMPACT Therapeutics, Inc

e6a67c547f.CezIaRgCtfPFazKb9q05A8pM-r796yVdlcsj-_iWIYQ.X72FG0tu9La1DVbLvOd3Ro0vrtyJqlQQ260buMn6T816r48-XC-Yu7IOWQ~431f857631292c7102d503e594344219

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - - +168.54%
+17.86%
+7.7%
+32.95%
+12.48%
+46%
+15.74%
-12.16%
+1.07%
+6.95%
Average +29.71%
Weighted average by Cap. +17.45%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
12.11CNY
Average target price
32.43CNY
Spread / Average Target
+167.74%
High Price Target
32.43CNY
Spread / Highest target
+167.74%
Low Price Target
32.43CNY
Spread / Lowest Target
+167.74%

Analyst Consensus Detail

Consensus revision (last 18 months)

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
12.11CNY
Average target price
32.43CNY
Spread / Average Target
+167.74%

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7630 Stock
  4. Consensus IMPACT Therapeutics, Inc